Related references
Note: Only part of the references are listed.The Global Ascendency of OXA-48-Type Carbapenemases
Johann D. D. Pitout et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases
J. M. Kidd et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Human-Simulated Antimicrobial Regimens in Animal Models: Transparency and Validation Are Imperative
Christian M. Gill et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Multidrug-Resistant Bacterial Infections in US Hospitalized Patients, 2012-2017
John A. Jernigan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
Jurgen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Efficacy of Human-Simulated Epithelial Lining Fluid Exposure of Meropenem-Nacubactam Combination against Class A Serine β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Murine Lung Infection Model
Tomefa E. Asempa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Epidemiology of carbapenem-resistant Enterobacteriaceae: a 5-year experience at a tertiary care hospital
Darunee Chotiprasitsakul et al.
INFECTION AND DRUG RESISTANCE (2019)
In Vivo Pharmacodynamic Profile of Ceftibuten-Clavulanate Combination against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in the Murine Thigh Infection Model
Kamilia Abdelraouf et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
WCK 5222 (Cefepime-Zidebactam) Pharmacodynamic Target Analysis against Metallo-β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Mouse Pneumonia Model
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review
Aaron J. Heffernan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
The epidemiology of nonventilator hospital-acquired pneumonia in the United States
Karen K. Giuliano et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2018)
Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects
Keith A. Rodvold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Treatment of Infections by OXA-48-Producing Enterobacteriaceae
Adam Stewart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model
Lindsay M. Avery et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases
Helio S. Soder et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Latania K. Logan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
Nikolas J. Onufrak et al.
CLINICAL THERAPEUTICS (2016)
Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns
Catia Cilloniz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Pharmacokinetics and Penetration of Ceftazidime and Avibactam into Epithelial Lining Fluid in Thigh- and Lung-Infected Mice
Johanna Berkhout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
In Vivo Efficacy of a Human-Simulated Regimen of Ceftaroline Combined with NXL104 against Extended-Spectrum-β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Enterobacteriaceae
Dora E. Wiskirchen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid Focus on Antibacterial Agents
Keith A. Rodvold et al.
CLINICAL PHARMACOKINETICS (2011)
Pharmacodynamics of Levofloxacin in a Murine Pneumonia Model of Pseudomonas aeruginosa Infection: Determination of Epithelial Lining Fluid Targets
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae:: Implications for breakpoint determinations
DP Nicolau et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
